Gå til innholdet
Menu

PHARMAQ’s manufacturing facility

All PHARMAQ's vaccines are manufactured at our well recognized facility at Overhalla in Norway. We are proud to meet the stringent requirements from various authorities for pharmaceutical industry quality systems. The manufacturing capacity is adapted to the growing demand for a variety of vaccines.

As a pharmaceutical company, PHARMAQ is subject to very stringent demands, regulated in the principles and guidance of Good Manufacturing Practice (GMP). PHARMAQ’s manufacturing facility is, on a regular basis, -approved according to GMP by the Norwegian Medicines Agency (NoMA).

Our focus on quality is absolute in all steps of production, from raw materials to finished products.

Quality is built in every operation, from development to the final product is approved by the authorities and released for sale by a QP (Qualified Person - approved by the authorities).

Manufacturing vaccines requires highly qualified personnel with special knowledge of aseptic production in a technical environment. Comprehensive training programs and validations are important activities to secure the run and maintenance of production equipments in the different process lines.

PHARMAQ manufacturing facility

PHARMAQ AS
Industrivegen 50
7863 Overhalla, Norway
Tel +47 74 28 08 00
Fax +47 74 28 08 01
E-mail customer.service​@pharmaq.no

Norway

Head office
Production facility
PHARMAQ AS
Skogmo Industriområde
Industrivegen 50
7863 Overhalla, Norway
Tel:+47 74 28 08 00
Fax:+47 74 28 08 01

Oslo office
PHARMAQ AS
Harbitzalléen 2A, 0275 Oslo,
P.O.Box 267 Skøyen, N-0213 Oslo, Norway
Tel: +47 23 29 85 00
Fax: :+47 23 29 85 01
customer.service​@pharmaq.no

Chile

PHARMAQ AS Chile Ltda.
Anibal Pinto # 200, oficina 61,
Puerto Montt, Chile
Tel: +56 65 248 3091
customer.service​@pharmaq.no

United Kingdom

PHARMAQ Ltd.
Unit 15 Sandleheath Industrial Estate,
Fordingbridge,
Hampshire SP6 1PA,
United Kingdom
Tel: +44 1425 656081
Fax: +44-1